Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.21037/tau.2018.06.01 http://scihub22266oqcxt.onion/10.21037/tau.2018.06.01 C6043752!6043752!30050800     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transl+Androl+Urol 2018 ; 7 (3): 399-413 Nephropedia Template TP {{tp|p=30050800|t=2018. Contemporary role of postoperative radiotherapy for prostate cancer |pdf=|usr=}}{{30050800}} gab.com Text Contemporary role of postoperative radiotherapy for prostate cancer JO: Transl Androl Urol http://www.kidney.de/pget.php?&tw=1&pmid=30050800 #FOAvip While radical prostatectomy (RP) has provided long-term disease control for the majority of patients with localized prostate cancer (CaP), nearly 30% of all surgical patients have disease progression. For high-risk patients, more than half of men experience disease recurrence within 10 years. Postoperative radiotherapy is the only known potentially curative treatment for a large number of patients following prostatectomy. Lately, there have been several advances with the potential to improve outcomes for patients undergoing postoperative radiotherapy. This article will give an overview of the existing literature and current controversies on: (I) timing of postoperative radiation; (II) use of concomitant androgen deprivation therapy; (III) optimal dose to the prostate bed; (IV) use of hypofractionation; (V) elective treatment of the pelvic lymph nodes; (VI) novel imaging modalities, and (VII) genomic biomarkers. Twit Text FOAVip Contemporary role of postoperative radiotherapy for prostate cancer ????Transl Androl Urol http://www.kidney.de/pget.php?&tw=1&pmid=30050800 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=30050800 #FOAvip English Wikipedia <ref>{{Cite pmid|30050800}}</ref> Contemporary role of postoperative radiotherapy for prostate cancer #MMPMID30050800 Dal Pra A; Abramowitz MC; Stoyanova R; Pollack A Transl Androl Urol 2018[Jun]; 7 (3): 399-413 PMID30050800show ga While radical prostatectomy (RP) has provided long-term disease control for the majority of patients with localized prostate cancer (CaP), nearly 30% of all surgical patients have disease progression. For high-risk patients, more than half of men experience disease recurrence within 10 years. Postoperative radiotherapy is the only known potentially curative treatment for a large number of patients following prostatectomy. Lately, there have been several advances with the potential to improve outcomes for patients undergoing postoperative radiotherapy. This article will give an overview of the existing literature and current controversies on: (I) timing of postoperative radiation; (II) use of concomitant androgen deprivation therapy; (III) optimal dose to the prostate bed; (IV) use of hypofractionation; (V) elective treatment of the pelvic lymph nodes; (VI) novel imaging modalities, and (VII) genomic biomarkers. äContemporary role of postoperative radiotherapy for prostate cancer (epmc).pdf DeepDyve Pubget Overpricing